Please do not leave this page until complete. This can take a few moments.
In an interview with HBJ's Sujata Srinivasan, Madhavi Gorusu, an oncologist and assistant clinical professor at the University of Connecticut School of Medicine, explains the basics of monoclonal antibody drugs.
How does a monoclonal antibody drug treat cancer?
Antibodies are proteins that target specific antigens such as bacteria and viruses, which cause the immune system to produce antibodies against it. Antibodies attach to antigens and the process activates the body's immune system to destroy the cells containing the antigens. Our body naturally produces antibodies as part of the immune system's response to germs, vaccines, etc. Many copies of a specific antibody can be made in the lab, which can be engineered to target a specific antigen expressed by cancer cells.
Monoclonal antibodies are manufactured using a type of cell called hybridoma, engineered by fusing an antibody-producing immune cell called B cell to a tumor cell. Hybridoma then multiplies to produce a continuous supply of specific antibodies. When the monoclonal antibody attaches itself to the cancer cell, it marks the cancer cell and makes it easier for the immune system to find and destroy it.
To date, the FDA has approved at least 12 different monoclonal antibody treatments for cancer.
How effective and safe is it?
Monoclonal antibody treatment is different from traditional chemotherapy drugs in that they are targeted therapies, which selectively attach to cancer cells. This means better efficacy and relatively fewer side effects. On the other hand, traditional chemotherapy medications lack the ability to differentiate between normal cells and cancer cells. This results in several side effects. In certain combinations, monoclonal antibodies can be combined with chemotherapy or radiation to produce synergistic effects.
What is the role of Receptor Tyrosine Kinases (RTKs) in cancer?
RTKs are key elements of signal transduction pathways that mediate cell- to-cell communication. They are transmembrane receptors, which play an important role in cell growth. Certain RTKs are overexpressed and activated in many types of cancers and ultimately are one of the key pathways for tumor growth. One of the strategies to prevent this cell-to-cell communication and thereby prevent cancer cell growth is by using antibodies against RTKs.
What are some challenges with RTK inhibitors?
One of the challenges in the successful treatment with RTK inhibitors is development of drug resistance by patients.
This special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Learn moreHartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
SubscribeDelivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
Read HereThis special edition informs and connects businesses with nonprofit organizations that are aligned with what they care about. Each nonprofit profile provides a crisp snapshot of the organization’s mission, goals, area of service, giving and volunteer opportunities and board leadership.
Hartford Business Journal provides the top coverage of news, trends, data, politics and personalities of the area’s business community. Get the news and information you need from the award-winning writers at HBJ. Don’t miss out - subscribe today.
Delivering Vital Marketplace Content and Context to Senior Decision Makers Throughout Greater Hartford and the State ... All Year Long!
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments